Patent · US Active

Compositions and methods for inhibiting expression of XBP-1 gene

US8765932B2 · kind B2 · utility

4Cited by
2References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2012
Grant dateJul 1, 2014
Priority date
Expiry dateSep 14, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/321
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting X-Box Protein 1 (XBP-1), and methods of using the dsRNA to inhibit expression of XBP-1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.